. This analyze indicates the likely utilization of tucidinostat while in the treatment of MM Later on (Huang et al., 2019). Sunlight et al. disclosed that tucidinostat is efficient in MM treatment through regulating levels of H3K27ac to boost the transcription of succinate dehydrogenase subunit A ( Adenoid cystic carcinoma https://stevez211kvf3.blog2news.com/profile